FDA recall record

Benzonatate Capsules, USP, 100 mg, 100 Capsules recall — FDA D-0257-2024

Superpotent drug: Assay results were slightly above specification at the time zero point.

Class IIIclassification
D-0257-2024official record ID
Jan 31, 2024report date

Recall record at a glance

Official recordD-0257-2024
CategoryDrug Recalls
ClassificationClass III
FDA record statusOngoing
Recalling firmAmerisource Health Services LLC
Report dateJan 31, 2024
Recall initiation dateDec 26, 2023
Quantity6,344 cartons
LocationColumbus, OH, United States

Official product description

Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11

Why the product was recalled

Superpotent drug: Assay results were slightly above specification at the time zero point.

Distribution information

Nationwide in the USA

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.